AAN’s Autoimmune Neurology Conference reviews immune-mediated disease across the central and peripheral nervous systems. The August 7–8, 2026 meeting at Marriott Marquis Houston addressed myasthenia gravis, autoimmune encephalitis, NMOSD, MOG-associated disease, inflammatory neuropathies and myelopathy. The listed program also includes paraneoplastic syndromes, emerging diagnostics, CAR-T cell therapies and case discussions. This English-language MedicalAmboss package is listed as videos, slides and posters. It is relevant to neurologists and trainees seeking a focused neuroimmunology review. The twenty-one store-listed session labels are retained below in their original order, including the keynote topics and closing debates.
Package scope: The session outline is not a verified file inventory or guarantee of completeness. Official AAN registration, publisher account access and provider access periods are separate from this purchase.
Topics
- C1 | Autoimmune Neurology Updates
- C2 | Myasthenia Gravis: Pathophysiology to Effective Treatments
- C3 | Keynote: The Glymphatic System
- C4 | Neuro-rheumatology
- C5 | Inflammatory Myopathies and Autoimmune Neuromuscular Junction Disorders
- C6 | Genetics and Neurological Autoimmunity
- C7 | Keynote: Paraneoplastic Neurological Syndromes
- C8 | Case Studies
- C9 | Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disease (NMOSD)
- C10 | Demyelinating Neuropathies
- C11 | Autoimmune and Infectious Encephalitis and Acute Seizures
- C12 | MOG-antibody Associated Disease
- C13 | Other Inflammatory Neuropathies
- C14 | Autoimmune Encephalitis: Pathophysiology to Treatment
- C15 | Clinical Approach to Suspected Myelopathy
- C16 | Autoimmune Movement Disorders
- C17 | Cancer-associated Neurological Autoimmunity
- C18 | Neurosarcoidosis
- C19 | Focus on Emerging Diagnostics
- C20 | CAR-T Cell Therapies and Neurology
- C21 | Closing Debates




